Abu dhabi: The 2nd International Ferticlinic Fertility and IVF Conference (2nd IFFIC) has wrapped up in Abu Dhabi, following two days filled with scientific dialogue, panel discussions, and hands-on educational sessions that brought together top global experts, healthcare leaders, and decision-makers.
According to Emirates News Agency, the conference underscored Abu Dhabi's growing status as a global hub for reproductive medicine and IVF technologies. The event concluded with the announcement of the results of a scientific research competition focused on impregnation and fertility technologies, which saw strong participation from physicians and university students from the UAE, including institutions such as Khalifa University, the University of Sharjah, and Ras Al Khaimah University.
The competition aimed to engage young researchers in scientific inquiry early on, stimulating innovation in reproductive medicine. Outstanding studies were honored with financial prizes to support academic and research careers, aligning with the conference's vision of preparing a new generation of scientists and researchers in this crucial field.
Khalifa University secured first place in the competition, with Dr. Yassin Al Mahi receiving the top award. Second place was awarded to Dr. Nigar Mehtiyeva from the University of Ras Al Khaimah, with Dr. Arwa Ibrahim, also from the University of Ras Al Khaimah, taking third place. Fourth place was shared by Dr. Binh Vu Thanh and Dr. Thanh Dao Huy.
Dr. Nagwan Ahmed, Conference President, remarked on the initiative's importance in transforming Abu Dhabi from a treatment hub into a global platform for knowledge creation and scientific research. Dr. Elsamawal El Hakim, CEO and Medical Director of the Ferticlinic Group, emphasized that supporting young talent and scientific research is a strategic investment, reinforcing the UAE's role as a reference hub for IVF technologies and medical education.
The conference concluded with recommendations highlighting the importance of international knowledge exchange, expanded research collaboration, and the adoption of the latest innovations within ethical and regulatory frameworks. It featured over 65 international speakers and drew thousands of participants from across the fertility sector, discussing advances in assisted reproductive technologies, fertility preservation, fetal medicine, genetics, and complex reproductive cases, as well as the role of artificial intelligence in improving treatment outcomes.